ADIPOQ and acromegaly: Many studies evaluating cardiovascular and metabolic biomarkers in acromegaly have been reported in the literature, though no clinical utility has been found for assessing levels of adiponectin, total homocysteine, or H19 ribonucleic acid (RNA) as markers of cardiovascular complications in acromegaly patients [12,13,14].